SS
INSM icon

Steve Schonfeld’s Insmed INSM Stock Holding History

Steve Schonfeld’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Buy
104,378
+48,322
+86% +$5.85M 0.04% 390
2026
Q1 		$9.17M Buy
+56,056
New +$8.62M 0.06% 322
2025
Q4 		– Sell
-60,635
Closed -$8.73M – 2284
2025
Q3 		$8.73M Sell
60,635
-22,804
-27% -$2.79M 0.05% 391
2025
Q2 		$8.4M Buy
83,439
+67,218
+414% +$5.14M 0.06% 391
2025
Q1 		$1.24M Buy
16,221
+7,961
+96% +$609K 0.01% 1192
2024
Q4 		$570K Sell
8,260
-31,572
-79% -$2.27M ﹤0.01% 1336
2024
Q3 		$2.91M Sell
39,832
-38,140
-49% -$2.81M 0.02% 739
2024
Q2 		$5.22M Sell
77,972
-291,946
-79% -$11.3M 0.03% 536
2024
Q1 		$10M Buy
369,918
+290,544
+366% +$8.13M 0.07% 379
2023
Q4 		$2.46M Sell
79,374
-124,026
-61% -$3.22M 0.02% 731
2023
Q3 		$5.14M Buy
+203,400
New +$4.65M 0.04% 541
2023
Q2 		– Sell
-37,661
Closed -$642K – 2310
2023
Q1 		$642K Buy
37,661
+27,561
+273% +$535K 0.01% 1098
2022
Q4 		$202K Sell
10,100
-12,979
-56% -$251K ﹤0.01% 1988
2022
Q3 		$497K Sell
23,079
-42,139
-65% -$1.01M ﹤0.01% 1756
2022
Q2 		$1.29M Buy
+65,218
New +$1.37M 0.01% 905
2021
Q1 		– Sell
-22,807
Closed -$759K – 1956
2020
Q4 		$759K Buy
22,807
+11,565
+103% +$422K 0.01% 902
2020
Q3 		$362K Buy
+11,242
New +$323K 0.01% 1023
2019
Q4 		– Sell
-13,200
Closed -$233K – 1374
2019
Q3 		$233K Sell
13,200
-9,800
-43% -$189K 0.01% 866
2019
Q2 		$589K Buy
+23,000
New +$641K 0.02% 587
2017
Q4 		– Sell
-9,106
Closed -$284K – 802
2017
Q3 		$284K Sell
9,106
-38,904
-81% -$741K 0.03% 462
2017
Q2 		$824K Buy
+48,010
New +$820K 0.09% 311

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Steve Schonfeld's INSM Position: Q2 2026 in Review

Steve Schonfeld increased its Insmed (INSM) stake by 86% in Q2 2026, buying an estimated $5.85M and bringing the position to 104,378 shares worth $11.1M. The position accounts for 0.04% of the portfolio, ranked #390.

Steve Schonfeld first reported a position in INSM in Q2 2017 and has held it in 21 quarters since. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Steve Schonfeld held 104,378 shares of Insmed worth $11.1M as of Q2 2026.
  • Steve Schonfeld bought 48,322 Insmed shares in Q2 2026, an estimated $5.85M.
  • Insmed made up 0.04% of Steve Schonfeld's portfolio in Q2 2026, its #390 holding.
  • Steve Schonfeld first reported a position in Insmed in Q2 2017 and has held it in 21 quarters since.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.